# PCP4

## Overview
PCP4, or Purkinje cell protein 4, is a gene that encodes a small calmodulin-binding protein, which plays a crucial role in calcium signaling pathways. The protein, also referred to as PCP4, is characterized by the presence of an IQ motif, enabling it to interact with calmodulin, a calcium-binding messenger protein. This interaction is pivotal in modulating various cellular processes, including neuronal differentiation, synaptic plasticity, and cardiac electrophysiology. PCP4 is predominantly expressed in the brain, particularly in the Purkinje cells of the cerebellum, and in the cardiac ventricular conduction system, where it influences both neuronal and cardiac functions. The protein's ability to regulate calcium-binding dynamics and inhibit CaMKII activity underscores its importance in maintaining normal cellular excitability and preventing arrhythmic behavior (Kim2014PCP4; Mouton-Liger2014Developmental).

## Structure
PCP4, also known as Purkinje cell protein 4, is a small protein that contains an IQ motif, which is a sequence known for its role in calmodulin binding. The primary structure of PCP4 includes this IQ motif, which is crucial for its interaction with calmodulin, a calcium-binding messenger protein (Kim2014PCP4). The secondary structure of PCP4 may involve typical protein folding patterns such as alpha helices and beta sheets, although specific details are not provided in the context.

PCP4 is part of the calpacitin family, which includes proteins that modulate calmodulin-dependent processes (Kim2014PCP4). This family is characterized by its ability to influence calcium signaling pathways, which are essential for various cellular functions. PCP4's interaction with calmodulin significantly increases the calcium-binding rate constants, suggesting a role in modulating cellular electrophysiology (Kim2014PCP4).

Post-translational modifications such as phosphorylation may occur, affecting the protein's function and interactions. While the context does not provide specific information on quaternary structures or splice variant isoforms, PCP4's involvement in calcium signaling and its expression in specific brain regions like the Purkinje cells of the cerebellum highlight its functional significance (San2014Distinct).

## Function
PCP4 (Purkinje cell protein 4) is a calmodulin-binding protein that plays a significant role in modulating calcium signaling pathways, which are crucial for various cellular processes. In healthy human cells, PCP4 is primarily expressed in the brain, with high levels in Purkinje cells of the cerebellum, where it influences neuronal differentiation and plasticity (Mouton-Liger2014Developmental; San2014Distinct). PCP4 regulates the activation of Ca2+-calmodulin targets, particularly CaMKII, a protein kinase involved in neuronal differentiation and synaptic plasticity (Mouton‐Liger2011PCP4; Mouton-Liger2014Developmental).

In the cardiac system, PCP4 is expressed in the ventricular conduction system, specifically the His-Purkinje network, where it modulates cardiac electrophysiology by influencing calmodulin-Ca2+ binding. This modulation affects ion channel function and intracellular calcium handling, playing a critical role in maintaining normal cardiac rhythmicity and preventing arrhythmic behavior (Kim2014PCP4). The protein's ability to inhibit CaMKII activity is essential for maintaining normal membrane excitability and preventing arrhythmias (Kim2014PCP4). PCP4's expression in cardiac autonomic ganglia suggests it also modulates cardiac rhythmicity through autonomic tone (Kim2014PCP4).

## Clinical Significance
Alterations in the expression of the PCP4 gene have been implicated in several neurological and cardiac conditions. In the context of neurodegenerative and neurocognitive disorders, altered levels of PCP4 are associated with Down syndrome, Alzheimer's disease, Huntington's disease, and Parkinson's disease. Overexpression of PCP4 is hypothesized to contribute to the pathogenesis of Down syndrome, while increased levels are observed in Alzheimer's disease. Conversely, reduced expression is noted in the prefrontal cortex of alcoholics and in the basal ganglia in models of Huntington's and Parkinson's diseases (Wei2011Impaired).

In cardiac contexts, PCP4 plays a critical role in maintaining normal cardiac function by regulating calcium homeostasis and CaMKII activity. Downregulation of PCP4 is linked to enhanced CaMKII activity, leading to proarrhythmic behavior, including ventricular arrhythmias and conduction abnormalities. This downregulation is associated with autonomic dysregulation observed in neurological syndromes such as Parkinson's disease, Huntington's disease, and chronic alcoholism. PCP4 is identified as a potential arrhythmia-susceptibility gene, with its dysregulation predisposing individuals to arrhythmias (Kim2014PCP4). The absence of PCP4 expression in the His-Purkinje system specifically contributes to arrhythmogenic activity, as seen in Pcp4-null mice (Kim2014PCP4).

## Interactions
Purkinje cell protein 4 (PCP4) is known to interact with calmodulin, a key protein in calcium signaling pathways. This interaction is facilitated by PCP4's IQ motif, which allows it to bind both calcium-free and calcium-bound forms of calmodulin. Through this binding, PCP4 modulates calmodulin's function by accelerating the rates of calcium association and dissociation, thereby influencing calmodulin-mediated signaling pathways (Harashima2011Purkinje).

PCP4's interaction with calmodulin has significant effects on various cellular processes. For instance, it enhances the activation of calmodulin-dependent protein kinase II (CaMKII), which is crucial for neuronal differentiation and plasticity (Mouton-Liger2014Developmental). In cardiac cells, PCP4 regulates CaMKII activity, affecting cardiac rhythmicity and Purkinje cell excitability. The absence of PCP4 leads to increased CaMKII activity, resulting in dysregulated calcium handling and proarrhythmic behavior (Kim2014PCP4).

PCP4 also influences neurotransmitter release and neurite outgrowth in neuronal cells by interacting with calmodulin, which in turn affects ERK phosphorylation and other downstream signaling pathways (Harashima2011Purkinje). These interactions highlight PCP4's role in modulating calmodulin-dependent processes across different cell types.


## References


[1. (Wei2011Impaired) Peng Wei, Jay A. Blundon, Yongqi Rong, Stanislav S. Zakharenko, and James I. Morgan. Impaired locomotor learning and altered cerebellar synaptic plasticity in pep-19/pcp4-null mice. Molecular and Cellular Biology, 31(14):2838–2844, July 2011. URL: http://dx.doi.org/10.1128/MCB.05208-11, doi:10.1128/mcb.05208-11. This article has 84 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.05208-11)

[2. (San2014Distinct) Andrew San Antonio, Kristopher Liban, Taruna Ikrar, Eugene Tsyganovskiy, and Xiangmin Xu. Distinct physiological and developmental properties of hippocampal ca2 subfield revealed by using anti‐purkinje cell protein 4 (pcp4) immunostaining. Journal of Comparative Neurology, 522(6):1333–1354, March 2014. URL: http://dx.doi.org/10.1002/cne.23486, doi:10.1002/cne.23486. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cne.23486)

[3. (Harashima2011Purkinje) Shin‐ichi Harashima, Yu Wang, Takahiko Horiuchi, Yutaka Seino, and Nobuya Inagaki. Purkinje cell protein 4 positively regulates neurite outgrowth and neurotransmitter release. Journal of Neuroscience Research, 89(10):1519–1530, June 2011. URL: http://dx.doi.org/10.1002/jnr.22688, doi:10.1002/jnr.22688. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jnr.22688)

[4. (Mouton-Liger2014Developmental) François Mouton-Liger, Ignasi Sahún, Thibault Collin, Patricia Lopes Pereira, Debora Masini, Sophie Thomas, Evelyne Paly, Sabrina Luilier, Sandra Même, Quentin Jouhault, Soumia Bennaï, Jean-Claude Beloeil, Jean-Charles Bizot, Yann Hérault, Mara Dierssen, and Nicole Créau. Developmental molecular and functional cerebellar alterations induced by pcp4/pep19 overexpression: implications for down syndrome. Neurobiology of Disease, 63:92–106, March 2014. URL: http://dx.doi.org/10.1016/j.nbd.2013.11.016, doi:10.1016/j.nbd.2013.11.016. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.nbd.2013.11.016)

[5. (Mouton‐Liger2011PCP4) François Mouton‐Liger, Sophie Thomas, Revital Rattenbach, Laetitia Magnol, Vanessa Larigaldie, Aurelie Ledru, Yann Herault, Catherine Verney, and Nicole Créau. Pcp4 (pep19) overexpression induces premature neuronal differentiation associated with ca2+/calmodulin‐dependent kinase ii‐δ activation in mouse models of down syndrome. Journal of Comparative Neurology, 519(14):2779–2802, July 2011. URL: http://dx.doi.org/10.1002/cne.22651, doi:10.1002/cne.22651. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cne.22651)

[6. (Kim2014PCP4) Eugene E. Kim, Akshay Shekhar, Jia Lu, Xianming Lin, Fang-Yu Liu, Jie Zhang, Mario Delmar, and Glenn I. Fishman. Pcp4 regulates purkinje cell excitability and cardiac rhythmicity. Journal of Clinical Investigation, 124(11):5027–5036, October 2014. URL: http://dx.doi.org/10.1172/jci77495, doi:10.1172/jci77495. This article has 44 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci77495)